Rockland Immunochemicals Acquires TrueBlot® Product Line

  Rockland Immunochemicals Acquires TrueBlot® Product Line

Business Wire

GILBERTSVILLE, Pa. -- December 13, 2012

Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies
and antibody based tools for basic research, assay development, and
preclinical studies, today announced the acquisition of the TrueBlot^®
IP/Western blot product line from eBioscience, Inc., an Affymetrix
(NASDAQ:AFFX) company.

TrueBlot reagents enable researchers involved in cancer, cell signaling,
infectious disease as well as other life science disciplines to generate
publication-quality data in immunoprecipitation and Western blot experiments.
Western blotting, a critical assay that is a widely accepted analytical
technique in both scientific research and medical diagnosis, is used to
determine expression and quantitate target proteins in biological samples. The
global market for Western blotting products is estimated at one billion

"The acquisition of the TrueBlot product line expands Rockland’s Western blot
workflow product offerings and will allow our customers to perform protein
research in a more efficient and effective manner, ultimately saving time and
precious research dollars," commented Jim Fendrick, President and CEO of
Rockland Immunochemicals. "The TrueBlot brand has an excellent reputation and
is widely considered best-in-class among Western blotting reagents."

“As eBioscience continues to focus its efforts on our evolving flow cytometry,
immunoassay and immunohistochemistry applications in immunology, oncology and
other therapeutic areas, we are pleased that the TrueBlot product line is a
strong strategic fit for the Rockland portfolio,” added Don Tartre, General
Manager of eBioscience.

Rockland will market the TrueBlot IP/Western blot product line on its
e-commerce website and through its existing global distribution network.
Detailed product information can be found at

About Rockland Immunochemicals

Rockland Immunochemicals has supported the biopharma and diagnostic industries
with antibodies and antibody based tools™for basic research, assay
development and preclinical studies for 50 years. With facilities in
Pennsylvania, Rockland manufactures over 10,000 products ideally suited for
integration into various assays performed on different platforms including
western blot, immunohistochemistry (IHC), immunofluorescence (IF), microscopy,
ELISA and FLOW cytometry. Additional information about Rockland’s products and
services can be found on the company’s web site at

About eBioscience

Established in San Diego, CA in 1999, eBioscience, now an Affymetrix company,
is a world leader in immunology and oncology flow cytometry reagents.
eBioscience offers one of the world’s largest selections of antibodies, ELISAs
and proteins for life science research and diagnostic. More information can be
found on the company’s web site at

Like Rockland on Facebook


Rockland Immunochemicals, Inc.
Tabitha Bauman, Communications, 610-369-1008
Press spacebar to pause and continue. Press esc to stop.